.@SenFinance Chairman @ChuckGrassley and @SenKevinCramer: PDPRA not only increases transparency into the opaque practices of PBMs but also addresses the lack of transparency in manufacturer drug pricing decisions.https://www.washingtonexaminer.com/opinion/op-eds/sens-grassley-and-cramer-how-congress-can-fix-high-drug-prices …
0 replies
1 retweet
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.